Literature DB >> 16389379

The effect of surgical office-based thyroid ultrasound on clinical decision making.

B M Gogel1, K M Ferry, S A Livingston, T M McCarty, J A Kuhn.   

Abstract

An important diagnostic tool for the evaluation of thyroid disease, thyroid ultrasound has recently become available for use in surgical offices. The purpose of this report is to determine the lesional sensitivity of office-based thyroid ultrasound and its impact on clinical decision making. Surgical office-based thyroid ultrasound was performed on 49 consecutive patients who presented with thyroid disease. Indications for sonography included a solitary palpable nodule (n = 32), multiple palpable nodules (n = 3), diffuse enlargement (n = 5), or other hormonal or radiologic abnormalities (n = 9). Thyroid ultrasound demonstrated 104 lesions compared with 38 lesions found on physical examination (P < 0.0001). In the subpopulation who underwent scintigraphy (n = 10), 24 nodules were identified by ultrasound and only 10 nodules were identified by scan (P < 0.01). Overall, office-based thyroid ultrasound impacted the clinical management of 40 patients (80%): in 16 patients, thyroid ultrasound was the only modality that demonstrated a multinodular condition, thus contributing to a decision to avoid surgery; 19 patients had ultrasound-guided fine-needle aspiration of vaguely palpable or nonpalpable lesions; and 5 patients underwent ultrasound-guided cyst aspiration and follow-up. Office-based thyroid ultrasound performed by surgeons is a highly accurate imaging modality that identified significantly more lesions than physical examination or scintigraphy. Clinical management was affected through the identification of a multinodular process or through facilitation of accurate image-guided biopsy.

Entities:  

Year:  2000        PMID: 16389379      PMCID: PMC1317039          DOI: 10.1080/08998280.2000.11927673

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  Clinical versus ultrasound examination of the thyroid gland in common clinical practice.

Authors:  A Brander; P Viikinkoski; J Tuuhea; L Voutilainen; L Kivisaari
Journal:  J Clin Ultrasound       Date:  1992-01       Impact factor: 0.910

2.  Evaluation of ultrasound-guided fine-needle aspiration biopsy for thyroid nodules.

Authors:  T Hatada; K Okada; H Ishii; S Ichii; J Utsunomiya
Journal:  Am J Surg       Date:  1998-02       Impact factor: 2.565

3.  Treatment decisions in thyroid surgery based upon ultrasonography.

Authors:  M Cohen; E Lubin; M Olsha; J L Freeman; R Feinmesser
Journal:  Isr J Med Sci       Date:  1996-12

4.  High-resolution real-time ultrasonography of thyroid nodules.

Authors:  W Scheible; G R Leopold; V L Woo; B B Gosink
Journal:  Radiology       Date:  1979-11       Impact factor: 11.105

5.  Aspiration biopsy of superficial lesions: ultrasonic guidance with a linear-array probe.

Authors:  G Rizzatto; L Solbiati; F Croce; L E Derchi
Journal:  AJR Am J Roentgenol       Date:  1987-03       Impact factor: 3.959

6.  Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies.

Authors:  H Gharib; J R Goellner; D A Johnson
Journal:  Clin Lab Med       Date:  1993-09       Impact factor: 1.935

7.  Ultrasound scanning of the thyroid gland as a new diagnostic approach.

Authors:  Y Fujimoto; A Oka; R Omoto; M Hirose
Journal:  Ultrasonics       Date:  1967-07       Impact factor: 2.890

8.  Simultaneous fine-needle aspiration and core-needle biopsy of thyroid nodules.

Authors:  Q Liu; M Castelli; P Gattuso; R A Prinz
Journal:  Am Surg       Date:  1995-07       Impact factor: 0.688

  8 in total
  2 in total

1.  Innovations in surgical oncology at Baylor University Medical Center.

Authors:  Joseph A Kuhn; Tammy Fisher; Sheryl Livingston
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

Review 2.  Evidence-based assessment of the role of ultrasonography in the management of benign thyroid nodules.

Authors:  Lilah F Morris; Nagesh Ragavendra; Michael W Yeh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.